Clinical Trials Browser

Phase 1/2 × Neoplasms × Alemtuzumab × Clear all

NCT00983528 2020-08-12

Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 1/2 Terminated

6 enrolled 6 charts

LymphoidOther hematologic neoplasm

Leukemia, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma